FULCRUM THERAPEUTICS INC (FULC) Stock Analyst Earnings Estimates
NASDAQ:FULC - Nasdaq - US3596161097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.34M -66.91% | 2.805M -55.76% | 80M 2,752.05% | -100.00% | 10.929M | 35.534M 225.13% | 90.823M 155.59% | 161.17M 77.46% | 217.67M 35.06% | |||
| EBITDA YoY % growth | -109.72M -39.72% | -108.492M 1.12% | -18.241M 83.19% | -87.179M -377.93% | -95.523M -9.57% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -112.13M -38.35% | -110.664M 1.31% | -19.834M 82.08% | -85.248M -329.80% | -90.549M -6.22% | -94.851M -4.75% | -97.791M -3.10% | -77.209M 21.05% | -23.914M 69.03% | 40.772M 270.49% | 91.768M 125.08% | |
| Operating Margin | -1,768.61% | -3,945.24% | -24.79% | N/A | N/A | N/A | -894.79% | -217.28% | -26.33% | 25.30% | 42.16% | |
| EPS YoY % growth | -2.48 -8.30% | -1.58 36.29% | -0.22 86.08% | -1.19 -441.79% | -1.23 -3.22% | -1.01 18.13% | -1.06 -5.32% | -0.80 25.00% | -0.21 73.94% | 0.47 327.89% | 0.93 97.13% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 -134.00% | -0.30 14.03% | -0.31 1.29% | -0.28 -0.79% | -0.34 -13.79% | -0.37 -22.03% | -0.40 -30.00% |
| Revenue Q2Q % growth | -100.00% | ||||||
| EBITDA Q2Q % growth | -21.746M -140.76% | -22.726M -4.06% | -23.695M -32.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.418M -140.80% | -21.72M 5.82% | -21.697M -11.68% | -20.68M -11.16% | -19.89M 7.13% | -20.91M 3.73% | -22.44M -3.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.28 34.88% | -0.30 | 0.02 | 6.63% |
| Q4 2024 Q2Q % growth | -0.31 22.50% | -0.33 | 0.02 | 5.45% |
| Q3 2024 Q2Q % growth | -0.35 10.26% | -0.41 | 0.06 | 15.39% |
| Q2 2024 Q2Q % growth | 0.87 328.95% | -0.01 | 0.88 | 6,923.53% |
| Q1 2024 Q2Q % growth | -0.43 -4.88% | -0.45 | 0.02 | 3.64% |
| Q4 2023 Q2Q % growth | -0.40 20.00% | -0.43 | 0.03 | 7.88% |
| Q3 2023 Q2Q % growth | -0.39 23.53% | -0.44 | 0.05 | 12.10% |
| Q2 2023 Q2Q % growth | -0.38 54.22% | -0.45 | 0.07 | 16.20% |
| Q1 2023 Q2Q % growth | -0.41 35.94% | -0.46 | 0.05 | 11.75% |
| Q4 2022 Q2Q % growth | -0.50 13.79% | -0.50 | 0.00 | -0.06% |
| Q3 2022 Q2Q % growth | -0.51 10.53% | -0.62 | 0.11 | 18.32% |
| Q2 2022 Q2Q % growth | -0.83 -38.33% | -0.67 | -0.16 | -23.17% |
| Q1 2022 Q2Q % growth | -0.64 -18.52% | -0.64 | 0.00 | -0.11% |
| Q4 2021 Q2Q % growth | -0.58 9.38% | -0.74 | 0.16 | 21.83% |
| Q3 2021 Q2Q % growth | -0.57 18.57% | -0.66 | 0.09 | 13.59% |
| Q2 2021 Q2Q % growth | -0.60 9.09% | -0.64 | 0.04 | 5.81% |
| Q1 2021 Q2Q % growth | -0.54 33.33% | -0.67 | 0.13 | 19.42% |
| Q4 2020 Q2Q % growth | -0.64 9.86% | -0.74 | 0.10 | 13.46% |
| Q3 2020 Q2Q % growth | -0.70 27.84% | -0.67 | -0.03 | -5.04% |
| Q2 2020 Q2Q % growth | -0.66 92.83% | -0.79 | 0.13 | 16.62% |
| Q1 2020 Q2Q % growth | -0.81 | -0.77 | -0.04 | -5.41% |
| Q4 2019 Q2Q % growth | -0.71 | -0.85 | 0.14 | 16.64% |
| Q3 2019 Q2Q % growth | -0.97 | -3.04 | 2.07 | 68.06% |
| Q2 2019 Q2Q % growth | -9.21 | -3.16 | -6.05 | -191.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | 80M 8,990.91% | 37.276M | 42.724M | 114.62% |
| Q1 2024 Q2Q % growth | -100.00% | 367.343K | -367.343K | -100.00% |
| Q4 2023 Q2Q % growth | 871K 26.23% | 470.393K | 400.607K | 85.16% |
| Q3 2023 Q2Q % growth | 759K -35.68% | 1.073M | -314K | -29.26% |
| Q2 2023 Q2Q % growth | 880K -53.19% | 1.138M | -258K | -22.67% |
| Q1 2023 Q2Q % growth | 295K -88.61% | 1.15M | -855K | -74.35% |
| Q4 2022 Q2Q % growth | 690K -86.36% | 1.687M | -997K | -59.10% |
| Q3 2022 Q2Q % growth | 1.18M -76.11% | 2.594M | -1.414M | -54.51% |
| Q2 2022 Q2Q % growth | 1.88M -57.08% | 3.024M | -1.144M | -37.83% |
| Q1 2022 Q2Q % growth | 2.59M -45.93% | 4.023M | -1.433M | -35.62% |
| Q4 2021 Q2Q % growth | 5.06M 19.62% | 2.733M | 2.327M | 85.14% |
| Q3 2021 Q2Q % growth | 4.94M 167.03% | 2.295M | 2.645M | 115.25% |
| Q2 2021 Q2Q % growth | 4.38M 119.00% | 1.629M | 2.751M | 168.88% |
| Q1 2021 Q2Q % growth | 4.79M 538.67% | 1.454M | 3.336M | 229.44% |
| Q4 2020 Q2Q % growth | 4.23M | 1.332M | 2.898M | 217.57% |
| Q3 2020 Q2Q % growth | 1.85M | 561K | 1.289M | 229.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -0.59% | 2.62% |
| Revenue | N/A | N/A | N/A | N/A |